Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.

Gorelov VN, Dumon K, Barteneva NS, Palm D, Röher HD, Goretzki PE.

J Cancer Res Clin Oncol. 1995;121(4):219-24.

PMID:
7751320
2.

Point mutations of ras and Gs alpha subunit genes in thyroid tumors.

Horie H, Yokogoshi Y, Tsuyuguchi M, Saito S.

Jpn J Cancer Res. 1995 Aug;86(8):737-42.

PMID:
7559096
3.
4.

Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.

Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM.

Clin Endocrinol (Oxf). 1998 Sep;49(3):317-23.

PMID:
9861322
5.

Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.

Du Villard JA, Wicker R, Crespo P, Russo D, Filetti S, Gutkind JS, Sarasin A, Suárez HG.

Oncogene. 2000 Oct 5;19(42):4896-905.

6.

Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.

Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y, Uchida K.

Clin Cancer Res. 2004 Mar 15;10(6):2035-43.

7.

Gs alpha--identification of a gene highly expressed by insulinoma and other endocrine tumors.

Zeiger MA, Norton JA.

Surgery. 1993 Aug;114(2):458-62; discussion 462-3.

PMID:
8342148
8.

[Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis].

Boltze C, Hoang-Vu C, Schneider-Stock R, Lehnert H, Roessner A.

Verh Dtsch Ges Pathol. 2004;88:237-45. German.

PMID:
16892558
10.

G protein expression in human fetoplacental vascularization. Functional evidence for Gs alpha and Gi alpha subunits.

Bourgeois C, Duc-Goiran P, Robert B, Mondon F, Ferré F.

J Mol Cell Cardiol. 1996 May;28(5):1009-21.

PMID:
8762039
11.
12.

Specific PCR amplification for N-ras mutations in neoplastic thyroid diseases.

Kaihara M, Taniyama M, Tadatomo J, Tobe T, Tomita M, Ito K, Ban Y, Katagiri T.

Endocr J. 1994 Jun;41(3):301-8.

13.

Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.

Meneray MA, Fields TY, Bennett DJ.

Invest Ophthalmol Vis Sci. 1997 May;38(6):1261-70.

PMID:
9152245
14.
15.

Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.

Fluge Ø, Haugen DR, Lillehaug JR, Varhaug JE.

World J Surg. 2001 May;25(5):623-31.

PMID:
11369990
16.

Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.

O'Neill C, Wiehager B, Fowler CJ, Ravid R, Winblad B, Cowburn RF.

Brain Res. 1994 Feb 14;636(2):193-201.

PMID:
8012802
17.
18.

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.

PMID:
12618337
19.

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C.

Cancer Res. 1997 Nov 1;57(21):4710-3.

20.

Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas.

Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M, Obara T.

Surgery. 1999 Dec;126(6):1056-61; discussion 1061-2.

PMID:
10598188

Supplemental Content

Support Center